| Immune checkpoint inhibitor myocarditis: pathophysiological characteristics, diagnosis, and treatment N Palaskas, J Lopez‐Mattei, JB Durand, C Iliescu, A Deswal Journal of the American Heart Association 9 (2), e013757, 2020 | 347 | 2020 |
| The Evolving Immunotherapy Landscape and the Epidemiology, Diagnosis, and Management of Cardiotoxicity: JACC: CardioOncology Primer L Zhang, KL Reynolds, AR Lyon, N Palaskas, TG Neilan Cardio Oncology 3 (1), 35-47, 2021 | 107 | 2021 |
| Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer X Wang, NL Palaskas, SW Yusuf, J Abe, J Lopez-Mattei, J Banchs, ... Journal of Thoracic Oncology 15 (10), 1682-1690, 2020 | 85 | 2020 |
| Clinical strategy for the diagnosis and treatment of immune checkpoint inhibitor–associated myocarditis: a narrative review LH Lehmann, J Cautela, N Palaskas, AH Baik, WC Meijers, Y Allenbach, ... JAMA cardiology 6 (11), 1329-1337, 2021 | 83 | 2021 |
| Evaluation and management of cardiac tumors N Palaskas, K Thompson, G Gladish, AM Agha, S Hassan, C Iliescu, ... Current treatment options in cardiovascular medicine 20, 1-14, 2018 | 83 | 2018 |
| Inflammatory myositis in cancer patients receiving immune checkpoint inhibitors J Aldrich, X Pundole, S Tummala, N Palaskas, CR Andersen, M Shoukier, ... Arthritis & Rheumatology 73 (5), 866-874, 2021 | 78 | 2021 |
| Immune checkpoint inhibitor myocarditis: elucidating the spectrum of disease through endomyocardial biopsy NL Palaskas, A Segura, L Lelenwa, BA Siddiqui, SK Subudhi, ... European Journal of Heart Failure 23 (10), 1725-1735, 2021 | 64 | 2021 |
| An update on gender disparities in coronary heart disease care T Shah, N Palaskas, A Ahmed Current atherosclerosis reports 18, 1-8, 2016 | 63 | 2016 |
| Electrocardiographic manifestations of immune checkpoint inhibitor myocarditis JR Power, J Alexandre, A Choudhary, B Ozbay, S Hayek, A Asnani, ... Circulation 144 (18), 1521-1523, 2021 | 60 | 2021 |
| Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis AM Agha, P Parwani, A Guha, JB Durand, CA Iliescu, S Hassan, ... Open heart 5 (2), e000881, 2018 | 58 | 2018 |
| Targeted cancer therapies with pericardial effusions requiring pericardiocentesis focusing on immune checkpoint inhibitors N Palaskas, J Morgan, T Daigle, J Banchs, JB Durand, D Hong, A Naing, ... The American Journal of Cardiology 123 (8), 1351-1357, 2019 | 48 | 2019 |
| Safety of diagnostic and therapeutic cardiac catheterization in cancer patients with acute coronary syndrome and chronic thrombocytopenia C Iliescu, DV Balanescu, T Donisan, DE Giza, EDM Gonzalez, ... The American Journal of Cardiology 122 (9), 1465-1470, 2018 | 48 | 2018 |
| Modern radiotherapy and risk of cardiotoxicity E Koutroumpakis, NL Palaskas, SH Lin, J Abe, Z Liao, J Banchs, ... Chemotherapy 65 (3-4), 65-76, 2020 | 45 | 2020 |
| Chemotherapeutic agents and the risk of ischemia and arterial thrombosis SA Hassan, N Palaskas, P Kim, C Iliescu, J Lopez-Mattei, E Mouhayar, ... Current atherosclerosis reports 20, 1-9, 2018 | 45 | 2018 |
| Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy DV Balanescu, T Donisan, N Palaskas, J Lopez-Mattei, PY Kim, LM Buja, ... Cardiovascular Pathology 47, 107211, 2020 | 43 | 2020 |
| Cardiovascular manifestations of Erdheim–Chester disease AS Ghotra, K Thompson, J Lopez‐Mattei, D Bawa, R Hernandez, ... Echocardiography 36 (2), 229-236, 2019 | 31 | 2019 |
| Multimodality imaging in carcinoid heart disease AM Agha, J Lopez-Mattei, T Donisan, D Balanescu, CA Iliescu, J Banchs, ... Open heart 6 (1), e001060, 2019 | 29 | 2019 |
| Cardiomuscular biomarkers in the diagnosis and prognostication of immune checkpoint inhibitor myocarditis LH Lehmann, MB Heckmann, G Bailly, D Finke, A Procureur, JR Power, ... Circulation 148 (6), 473-486, 2023 | 24 | 2023 |
| Radiation-induced cardiovascular disease: mechanisms, prevention, and treatment E Koutroumpakis, A Deswal, SW Yusuf, J Abe, KT Nead, AS Potter, Z Liao, ... Current oncology reports 24 (5), 543-553, 2022 | 23 | 2022 |
| Machine learning-augmented propensity score analysis of percutaneous coronary intervention in over 30 million cancer and non-cancer patients DJ Monlezun, S Lawless, N Palaskas, S Peerbhai, K Charitakis, ... Frontiers in cardiovascular medicine 8, 620857, 2021 | 23 | 2021 |
